NCT07240480

Brief Summary

The goal of this observational methodological study is to validate the Turkish version of the DDIVAT visual acuity measuring device in a Turkish-speaking adult population. The main questions it aims to answer are: Does the Turkish version of the DDIVAT provide reliable and valid visual acuity measurements in Turkish speakers? Are the results of the DDIVAT comparable to those obtained with the standard Snellen chart used in clinical practice? Researchers will compare DDIVAT visual acuity test results with Snellen chart results to see if both methods produce consistent measurements. Participants will: Be adults aged 18 years or older, including both patients and healthy volunteers. Undergo visual acuity testing using the DDIVAT system displayed on a smart TV connected to the university server. Have their visual acuity re-measured using the standard Snellen optotype under the same conditions. No medication or invasive procedure will be used. The study carries no risk to participants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
Last Updated

December 4, 2025

Status Verified

October 1, 2025

Enrollment Period

5 months

First QC Date

November 16, 2025

Last Update Submit

November 26, 2025

Conditions

Keywords

Visual AcuityRefractive Errors

Outcome Measures

Primary Outcomes (1)

  • Agreement between DDIVAT (Turkish version) and Snellen chart visual acuity measurements

    The primary outcome is to assess the level of agreement between visual acuity scores obtained using the Turkish version of the DDIVAT digital visual acuity device and those obtained using the standard Snellen chart. Statistical analysis will include correlation and Bland-Altman agreement methods to evaluate consistency and validity between the two testing methods.

    During a single study visit (same day assessment)

Study Arms (1)

Participants Undergoing Visual Acuity Testing

All enrolled participants (n = 200) will complete two visual acuity measurements during a single visit: one using the DDIVAT (Digital Device Independent Visual Acuity Test) Turkish version and one using the standard Snellen chart. The study compares the agreement and test-retest reliability of these two methods. No intervention, medication, or treatment is applied.

Diagnostic Test: DDIVAT Visual Acuity Test (Turkish Version)

Interventions

Participants' visual acuity will be measured using the Turkish version of the DDIVAT digital visual acuity device and compared with Snellen chart results. No treatment or invasive procedure will be performed.

Participants Undergoing Visual Acuity Testing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Turkish-speaking adults (aged 18 and older), including both healthy volunteers and ophthalmology clinic patients, will be recruited from Trakya University Hospital, Department of Ophthalmology (Edirne, Türkiye).

You may qualify if:

  • Adults aged 18 years or older
  • Turkish-speaking individuals able to understand the study purpose
  • Willingness to participate and provide written informed consent
  • Participants with or without refractive errors (e.g., myopia, hyperopia, astigmatism)

You may not qualify if:

  • Age below 18 years
  • Individuals unable to complete visual acuity testing
  • Presence of severe ocular pathology (e.g., corneal opacity, retinal detachment) that prevents accurate measurement
  • Cognitive or communication difficulties preventing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Posar A, Visconti P. Early Motor Impairment in Children with Autism Spectrum Disorder. Turk Arch Pediatr. 2021 Nov;56(6):646-647. doi: 10.5152/TurkArchPediatr.2021.21168. No abstract available.

    PMID: 35110066BACKGROUND
  • Daiber HF, Gnugnoli DM. Visual Acuity. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK563298/

    PMID: 33085445BACKGROUND

Related Links

MeSH Terms

Conditions

Refractive ErrorsMyopiaHyperopiaAstigmatism

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Hande Güçlü, M.D., Prof. Dr.

    Trakya University Teaching and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmet Kaan Şimşek, Md.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Head - Ophthalmology (Trakya Univ.)-Principal Investigator

Study Record Dates

First Submitted

November 16, 2025

First Posted

November 21, 2025

Study Start

December 1, 2025

Primary Completion

April 30, 2026

Study Completion

May 31, 2026

Last Updated

December 4, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

This is a minimal-risk, non-interventional validation study conducted at a single institution. The collected data will be anonymized and analyzed internally. Individual participant-level data will not be shared outside Trakya University Faculty of Medicine due to institutional data-protection policies.